Question to the Department of Health and Social Care:

To ask His Majesty's Government what proportion of health technology assessments submitted to the National Institute for Health and Care Excellence in the past five years have related to cancer; and what assessment they have made of the importance of up-to-date national registry data to those evaluations.

In the financial years 2021/22 to 2025/26, to date, the National Institute for Health and Care Excellence (NICE) has made 429 technology appraisal recommendations. Of these appraisals, 218 relate to cancer medicines. The Department has not made any assessment of the importance of an up-to-date national registry on those evaluations. NICE works with companies and wider stakeholders throughout the appraisal process to ensure that its appraisals take into account the available evidence.